CDEK
← All drugs Report issue

eicosapentanoic acid

Small moleculeexperimental

Eicosapentaenoic acid (EPA; also icosapentaenoic acid) is an omega−3 fatty acid. In physiological literature, it is given the name 20:5(n−3). It also has the trivial name timnodonic acid. In chemical structure, EPA is a carboxylic acid with a 20-carbon chain and five cis double bonds; the first double bond is located at the third carbon from the omega end. — Wikipedia

Clinical trial activity

38 trials · 53 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
4
Phase 3
0
Phase 4
10

Earliest trial started Aug 31, 2010 (NCT01369550)

Timeline

2010s

  1. Jan 1, 2014

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2019

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • Unspecified targetUnclear

    Unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06975241Phase 4May 31, 2025University of Toronto
NCT06992323N/AFeb 17, 2025Government of Spain, Olivenova Health Sl
NCT06736925Phase 2Jan 31, 2025Indiana University, National Institute of Neurological Disorders and Stroke (NINDS)
NCT06758778N/AJan 3, 2025SICHUAN CREDIT PHARMACEUTICAL CO., LTD.
NCT06731400N/ADec 3, 2024University of Sao Paulo
NCT06494488Early Phase 1 (Phase 1)Aug 1, 2024Brown University, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH)
NCT06129526Phase 4Dec 31, 2023University of Ioannina
NCT06981676N/AJul 25, 2023Pontificia Universidad Catolica de Chile
NCT06833554N/AJan 1, 2023Government of Spain
NCT05438173N/AJul 11, 2022MB Clinical Research and Consulting LLC, Midwest Center for Metabolic and Cardiovascular Research, Naturmega
NCT04844034N/ASep 30, 2021University of Roehampton
NCT04897893Phase 4Apr 21, 2021Integrated Health and Social Services Centres (CISSS) de la Gaspésie, Integrated Health and Social Services Centres (CISSS) du Bas-St-Laurent, SCF Pharma
NCT04175769N/AJan 31, 2020University of Alberta, University of Calgary
NCT04159532Phase 4Dec 15, 2019SCF Pharma
NCT04126330N/ASep 11, 2019Orebro University, Pfizer, University of Hohenheim
NCT04006847Phase 1/Phase 2 (Phase 2)Aug 1, 2019Pennsylvania State University
NCT03972319Early Phase 1 (Phase 1)Jul 31, 2019Khoo Teck Puat Hospital
NCT03862872N/AJun 30, 2019Bend Beauty Inc., Cornerstone Naturopathic Clinic Inc.
NCT03915535Phase 4May 16, 2019SCF Pharma
NCT03801577N/AFeb 28, 2019BASF
Showing 20 of 38 trials
Page 1 / 2

Organizations

Research & Development (53)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
SCF PharmaFor profit4412018
BASFFor profit3112017
Government of SpainGovernment2212023
MB Clinical Research and Consulting LLCFor profit2022018
Midwest Center for Metabolic and Cardiovascular ResearchAcademic/Hospital2222018
Northumbria UniversityAcademic/Hospital2212017
A.O. Ospedale Maggiore di LodiAcademic/Hospital1112016
Bend Beauty Inc.For profit1112019
Bournemouth UniversityAcademic/Hospital1112017
Brown UniversityAcademic/Hospital1112024
Cornerstone Naturopathic Clinic Inc.Academic/Hospital1012019
Efamol LtdFor profit1012017
Government of OntarioGovernment1012017
Harvard UniversityAcademic/Hospital1112018
Indiana UniversityAcademic/Hospital1112025
Integrated Health and Social Services Centres (CISSS) de la GaspésieAcademic/Hospital1012021
Integrated Health and Social Services Centres (CISSS) du Bas-St-LaurentAcademic/Hospital1012021
Khoo Teck Puat HospitalAcademic/Hospital1112019
Kobe UniversityAcademic/Hospital1112013
Los Angeles Biomedical Research InstituteAcademic/Hospital1112018
53 organizations
Page 1 / 3